Chevron increases total investment to $55 million in the Global Fund to Fight AIDS, Tuberculosis and Malaria
05 October 2010
San Ramon, Calif., October 5, 2010 - Chevron Corporation (NYSE:CVX) today announced that it will commit an additional $25 million to The Global Fund to Fight AIDS, Tuberculosis and Malaria, raising its 6-year investment in the organization to $55 million. This is now the largest contribution from a single corporation. The Global Fund to Fight AIDS, Tuberculosis and Malaria is one of the largest funders of programs to fight global epidemics.
“Socioeconomic development and strong economies start with healthy communities,” said Rhonda Zygocki, Vice President, Policy, Government and Public Affairs for Chevron Corporation. “Our increased investment and continued partnership with the Global Fund reflects our long-term commitment to fight these deadly diseases in regions of the developing world where we have some of our largest operations.”
Chevron Corporation became The Global Fund’s inaugural Corporate Champion in January 2008, when it committed $30 million to support programs in Asia and Africa. The additional $25 million investment will help Chevron and The Global Fund build on significant results, which include:
- Helping more than 300,000 people living with HIV in Nigeria, Indonesia, South Africa and Thailand to obtain access to life-saving antiretroviral treatments
- Supporting efforts to distribute nearly 1 million insecticide-treated bed nets in Angola
- Promoting peer education programs in South Africa that have reached 1.9 million young people
- Helping to detect more than 9,000 cases of TB
Chevron has been at the forefront of the fight against AIDS since 1986 when it joined 13 other Bay Area companies to promote education and reduce stigma in the workplace. In the 1990’s, Chevron expanded efforts internationally and in 2005 the company implemented a global HIV/AIDS policy supporting employees and their families. Chevron initially chose The Global Fund as a partner in 2008 because its performance-based model provides an efficient and high-impact way to sustain healthy communities around the world. The Global Fund also places a major emphasis on measurement and evaluation of the programs it funds, ensuring that Chevron’s investments are making a tangible difference to the people who need it most.
“We appreciate our partnership with Chevron, a company which is truly committed to results-driven collaboration,” said Prof. Michel Kazatchkine, executive director of The Global Fund to Fight AIDS, Tuberculosis and Malaria. “The challenges facing us are bigger than any one sector can solve on its own. Governments, civil society and the private sector all have an important role to play in ensuring that we can deliver sufficient resources to treat those who are sick, to prevent new infections, and to improve the health of women and children. We need more companies to follow Chevron’s commendable example.”